Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2012, Article ID 512097, 6 pages
Review Article

Interface Molecules of Angiostrongylus cantonensis: Their Role in Parasite Survival and Modulation of Host Defenses

Laboratório de Biologia Parasitária Faculdade de Biociências e Laboratório de Parasitologia Molecular Instituto de Pesquisas Biomédicas Pontifícia Universidade do Rio Grande do Sul (PUCRS), 90690-900 Porto Alegre, RS, Brazil

Received 3 November 2011; Accepted 23 January 2012

Academic Editor: Kittisak Sawanyawisuth

Copyright © 2012 Alessandra L. Morassutti and Carlos Graeff-Teixeira. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Angiostrongylus cantonensis is a nematode parasite that causes eosinophilic meningoencephalitis in humans. Disease presents following the ingestion of third-stage larvae residing in the intermediate mollusk host and disease manifests as an acute inflammation of the meninges characterized by eosinophil infiltrates which release a battery of proinflammatory and cytotoxic agents in response to the pathogen. As a mechanism of neutralizing these host defenses, A. cantonensis expresses different molecules with immunomodulatory properties that are excreted or secreted (ES). In this paper we discuss the role of ES proteins on disease exacerbation and their potential use as therapeutic targets.

1. Introduction

Establishment of parasitic infections is dependent on a delicate and constant interaction between host and parasite, specifically, interactions between the host immune system and molecules released by the parasite or located at the parasite surface [1, 2]. Parasitic organisms have evolved the ability to survive in such hostile environments by evading or neutralizing host defense systems. This process is mediated in part by molecules released by parasites that consist of excretion and secretion (ES) products which may contain metabolites, enzymes, hormone-like factors, antioxidants, and proteinase inhibitors among others [3, 4].

Eosinophilic meningitis, also known as cerebral angiostrongyliasis, is an acute inflammation caused mainly due the presence of Angiostrongylus cantonensis young in the meninges, parenchyma of the medulla, pons, or cerebellum [5]. Humans get infected after ingestion of third-stage larvae residing in raw mollusks, vegetables, or contaminated water. To date, more than two thousand angiostrongyliasis cases have been reported, with most cases occurring in Southeast Asia and the Pacific Islands where the disease is endemic [6]. However, angiostrongyliasis cases have now been reported in regions of the world where this disease has not previously been reported, that is, Brazil, Caribe, Ecuador, Australia, and the USA. This change in the epidemiology of angiostrongyliasis should serve as a warning to authorities that this disease is an emerging public health problem [710].

The pathogenicity and pathophysiology of cerebral angiostrongyliasis, however, still remain poorly defined. The present paper discusses the potential role of excreted and secreted (ES) proteins in relation to Angiostrongylus infections in the context of developing novel diagnostic and treatment modalities.

2. Eosinophils and Meningoencephalitis

Eosinophils play a critical role in protection against helminthes and in mediating allergic responses. Eosinophils possess specialized granules containing a battery of proinflammatory and cytotoxic agents. In addition, various molecules, including interleukin- (IL-2), 4, 5, 10, 12, 13, 16, 18, TGF-α/β, leukotrienes, proteases, reactive oxygen species (ROS), and nitric oxide (NO) secreted by eosinophils can play important roles in mediating protective antihelminthic responses [11, 12]. However, producing these molecules can damage cell membranes and tissues, ultimately contributing to the pathogenesis and pathophysiology associated with hypereosinophilic syndromes [13].

Cerebral angiostrongyliasis is characterized by eosinophil infiltrates that kill immature worms residing in the meninges [14]. Sasaki and coworkers [15] demonstrated enhanced intracranial survival of A. cantonensis when eosinophilic responses were inhibited following treatment with anti-IL-5 antibodies [15]. By contrast, mice overexpressing IL-5 killed worms faster and female worms were smaller than those developing in wild-type mice [16]. The same results were observed with another Angiostrongylus species, for example, A. costaricensis that causes abdominal angiostrongyliasis, a disease also associated with eosinophilia [17].

IL-5 is an important cytokine associated with the progression of eosinophilia following an A. cantonensis infection [16]. Specifically, IL-5 levels were significantly elevated in the CSF and peripheral blood of patients with eosinophilic meningoencephalitis due to infections with A. cantonensis [18, 19], corroborating previous data generated in mouse models of disease [16, 20].

Several studies have focused on developing therapeutic strategies designed to prevent eosinophil infiltrates by eliciting a switch from a Th-2 to a Th-1 type of response. Du et al. [21] observed decreased IL-5 levels and elevated INF-γ levels in mice when an antihelminthic drug was administrated in combination with IL-12 in an experimental A. cantonensis infection model [21]. Another study using antihelminthic drugs in combination with steroids (to avoid severe inflammation due to larval death in the meninges) determined that in patients receiving both drugs, the IL-5 levels and peripheral eosinophil counts were reduced [19]. Recently, Chuang et al. demonstrated that administration of an anti-CCR3 monoclonal antibody that blocked the major receptor present on eosinophils (CCR3) reduced eosinophil infiltrates and consequently reduced the severity of neurological damage in mice [22].

These data suggested that controlling the level of eosinophil infiltrates and the polarization of Th-2 responses may reduce neurological damage resulting from A. cantonensis infections. A better understanding of the host-parasite interplay would facilitate the development of different approaches for disease treatment and reduction of disease-associated sequelae.

3. Released Angiostrongylus cantonensis Molecules and Their Potential Roles in Disease

Direct leucocyte chemoattractants for eosinophil cells have been found during in vitro studies of many parasites released molecules, including Angiostrongylus cantonensis [23]; however, the identity of those molecules is poorly known [24]. ES released by parasites are likely key to parasite survival since ES are continuously released and may promote tissue penetration, nutrient acquisition, and also immune system and oxidative stress evasion [3]. Studies of ES products from third-stage A. cantonensis larvae have demonstrated serine protease and metalloprotease activity likely associated with duodenal penetration [25]. We previously demonstrated the presence of high levels of antioxidant enzymatic activities in ES fractions of adult A. cantonensis worms, including superoxide dismutase (SOD) and catalase (CAT), which may be involved in parasite survival against oxidative stress generated by host immune responses [26]. Another recent study investigating immunoreactive proteins from adult ES preparations identified peroxiredoxin, serine proteases, heat-shock proteins, ferritin, galectin, aldolase, and proteases inhibitors [27]. The potential role of these proteins on inflammatory processes and disease exacerbation is discussed in the following.

3.1. Peroxiredoxin

Antioxidant proteins mediate important protective mechanism against ROS generated by the host immune response [3]. Peroxiredoxin (Prx) is an enzyme reported to exist in many parasites and known to play a central role in H2O2 detoxification. However, another function has been attributed to Prx; for example, Fasciola hepatica ES products containing Prx have been shown to downregulate Th-1 type responses and to affect macrophage activation following injection into mice [28]. In another study, neutralization of secreted Prx during the course of an F. hepatica infection significantly reduced the Th-2 responses [29], indicating that Prx is a target for disease treatment. Indeed, knocking down the S. mansoni Prx genes using RNA-i dramatically increased oxidative damage to parasite proteins and lipids, which in turn reduced worm survival [30]. Prx was found in ES products of adult A. cantonensis worms that were recognized by immunoglobulins present in the serum of infected patients [27]. Interestingly, as mentioned above, local Th-2 responses were implicated in the development of CSF and peripheral eosinophilia associated with A. cantonensis infections [16], and elimination of the worm combined with IL-12 administration shifted the response from a Th-2 to a Th-1 type response [21]. These observations raised the following hypothesis: blocking A. cantonensis Prx activity would make the parasite vulnerable and weaken the Th-2 response, making this molecule a viable treatment target.

3.2. Heat Shock Proteins

Heat shock proteins are a highly conserved group of proteins present in both prokaryotic and eukaryotic organisms. They are grouped into different families based on their molecular weights. HSPs function as chaperones, assisting in the proper folding of newly synthesized proteins even though HSPs were first associated with stress-induced stimuli [31]. HSP70 has been identified in ES preparations of many parasites, including A. cantonensis [27]. HSP70 is involved during adaptive response associated with the early stages of infection with the nematode Trichinella spiralis [32]; and HSPs have also been associated with drug resistance in various Leishmania spp. protozoans [33]. In addition, knocking down HSP90 in adult Caenorhabditis elegans worms using RNA-i resulted in cessation of egg production and in an embryonic lethal phenotype [34, 35]. Interestingly, inhibiting oviposition is of special interest as a new treatment alternative for abdominal angiostrongyliasis because eggs play a central role in pathogenesis [36], thereby making Angiostrongylus HSPs viable targets for disease treatment.

Administration of recombinant HSP from the protozoan Trypanosoma carassii activated goldfish macrophages in vitro and stimulated the production of the proinflammatory cytokines INFγ and TNFα [37]. Indeed, secreted HSP forms have been demonstrated to bind Toll-like receptors 2 and 4 (TLR2 and TLR4) expressed on the surface of antigen-presenting cells (APCs) in a similar manner as lipopolysaccharide (LPS) [38], resulting in the production of proinflammatory cytokines. Moreover, HSPs have been considered to play a role in the development and pathogenesis of some rheumatic diseases [39]. Together, these data suggested that released A. cantonensis HSPs may facilitate the inflammatory process, making further studies to better understand the role of this protein in disease pathology crucial.

3.3. Galectin

Galectins are a family of sugar-binding proteins with affinity for N-acetyl lactosamines, an interaction mediated via a conserved carbohydrate-recognition domain (CRD). In mammals, these proteins possess the ability of modulate inflammatory responses. Galectin-1 has been demonstrated to inhibit Th1 differentiation, leading to Th2 responses [40]. On the other hand, galectin-9, another mammalian galectin, has been shown to reduce Th2-associated airway inflammation [41]. However, the function of helminth galectins still remains unclear even though Brugia malayi and Onchocerca volvulus galectins have been hypothesized to function as potential immune modulators [42, 43]. One of the most important classes of antigens expressed by several helminths is comprised of sugar molecules. Interestingly, helminthes activate innate immune cells via surface-expressed or -secreted products, including glycolipids and glycoproteins, through lectin receptors [44]. This association may interfere with the induction of effective immune responses that could contribute to the modulation of inflammatory T-cell responses [45]. In fact, the Schistosoma egg glycan did not upregulate stimulatory molecules or produce cytokines when it was recognized and internalized by immature dendritic cells (iDCs), indicating that conventional maturation of dendritic cells induced by Toll-like receptors agonists was prevented [46]. Moreover, galectins have also been identified as targets for disease diagnosis, for example, diagnosis of Trichostrongylus colubriformis (gastrointestinal nematode) infections in sheep [47]. In similar fashion, an ES galectin from A. cantonensis was shown to be immunoreactive to antibodies present in serum from angiostrongyliasis patients, further supporting the potential use of this protein as a diagnostic antigen [27].

3.4. Proteases

Proteases are enzymes that catalyze the cleavage of amide linkages in macromolecular proteins and oligomeric peptides. Proteases are very important for parasite survival because they facilitate tissue penetration and nutrient acquisition. For example, hemoglobinases are proteases that degrade hemoglobin into peptides and amino acids, a fundamental process for nutrient acquisition for many parasites. Hemoglobinases from hookworms have been suggested as potential vaccine targets because of their immunogenicity and because their inactivation would interfere with hookworm feeding [48]. Our previous work demonstrating that hemoglobinases present in ES products from adult worms were recognized by sera from angiostrongyliasis-infected patients supports these observations. In addition, these enzymes may constitute therapeutic targets as observed by Sijwali et al. [49] who demonstrated that disruption of falcipain-2 protein (an enzyme involved in Plasmodium falciparum hemoglobin degradation) resulted in fitness injuries to early-stage trophozoites [49]. It is reasonable therefore to hypothesize that blocking hemoglobinase activity would interfere with nutrient uptake resulting in death of the parasite. In fact, knocking down an S. mansoni hemoglobinase resulted in significant growth retardation in vitro [50]. A parallel approach targeting enzymes responsible for sugar digestion (such as aldolase and beta-amylase) could also result in parasite elimination.

Another protein identified in ES samples was a cathepsin B-like protein, which is a cysteine protease. Cystein proteases from helminthes have been shown to be involved in degrading host proteins, including immunoglobulins, complement components, kininogen, hemoglobin, albumin, and extracellular matrix proteins [51]. Interestingly, cysteine proteases from ES preparations of Paragonimus westermani, a tissue-invasive parasite that causes either pulmonary or extrapulmonary paragonimiasis in humans, were also implicated in human eosinophil degranulation in vitro [52]. These findings may help in the understanding of the mechanisms of tissue inflammation associated with meningoencephalitis due to A. cantonensis infections since the cathepsin B-like protein was secreted by the parasite.

3.5. Proteases Inhibitors

Besides secreted proteases, parasitic organisms also have the ability to produce and release inhibitors for many types of proteases that may block host protease function, thereby facilitating parasite survival. Three kinds of protease inhibitors are commonly described in parasites: aspins, specific to aspartic proteases, cystatins, which block the activity of cysteine proteases, and serpins, which act on serine proteases.

A cystatin from A. cantonensis (AcCystatin) was identified from a cDNA library of fourth-stage larvae that was cloned and expressed in a prokaryotic system. The authors observed that recombinant AcCystatin significantly inhibited cathepsin B and significantly upregulated nitric oxide production by IFNγ-activated macrophages [53]. Interestingly, cystatins identified from parasitic nematodes have been implicated in blocking cathepsin activity; however, they are also associated with stimulating the production of anti-inflammatory cytokines [54]. These cystatin properties suggest that they can inhibit cellular proliferation while concomitantly establishing an anti-inflammatory environment favorable to parasite survival [55]. As therapeutic targets, these inhibitors have been demonstrated to prevent allergic inflammation in both lung and intestines of mice treated with a filarial cystatin that modulated macrophage-mediated colitis, in addition to inhibiting eosinophil recruitment, downregulating IL-4 production, and suppressing allergic airway hyper-reactivity [56].

An aspartyl protease inhibitor secreted by A. cantonensis female adult worms was identified in an in vitro study [27]; however, the role of aspins in helminthes is not clear. Potentially, these proteins could block the activity of host aspartyl proteases. Nevertheless, the activity of porcine pepsin was not inhibited by a recombinant hookworm aspartic proteinase inhibitor [57]. To date, only aspins have been reported in the role of A. cantonensis proteinase inhibitors [58]. However, molecular analysis of the A. cantonensis genome revealed that only a small number of sequences have been deposited at Genbank. As a consequence, protein identification by mass spectrometry is ineffective since the lack of peptide sequence homology to related proteins from other organisms makes identification difficult.

4. Conclusions

The pathogenesis of eosinophilic meningitis is related to the development of significant inflammatory reactions in response to A. cantonensis worms residing in the nervous system. In response to the infection, eosinophils are recruited and several potent cytotoxic agents are released in an attempt to eliminate the pathogen. This immune-mediated attack frequently results in tissue damage and ultimately may exacerbate disease severity. In this paper, we discussed the putative diverse roles of released A. cantonensis molecules. Many kinds of molecules may act as immunomodulators, but these molecules may also be involved in disease exacerbation. Further studies using recombinant forms of the target proteins discussed above will be essential in evaluating and confirming the hypothesis presented here.


  1. R. M. Maizels, D. A. P. Bundy, M. E. Selkirk, D. F. Smith, and R. M. Anderson, “Immunological modulation and evasion by helminth parasites in human populations,” Nature, vol. 365, no. 6449, pp. 797–805, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. K. Henkle-Dührsen and A. Kampkötter, “Antioxidant enzyme families in parasitic nematodes,” Molecular and Biochemical Parasitology, vol. 114, no. 2, pp. 129–142, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Dzik, “Molecules released by helminth parasites involved in host colonization,” Acta Biochimica Polonica, vol. 53, no. 1, pp. 33–64, 2006. View at Google Scholar · View at Scopus
  4. J. P. Hewitson, J. R. Grainger, and R. M. Maizels, “Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity,” Molecular and Biochemical Parasitology, vol. 167, no. 1, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. C. Graeff-Teixeira, A. C. A. Da Silva, and K. Yoshimura, “Update on eosinophilic meningoencephalitis and its clinical relevance,” Clinical Microbiology Reviews, vol. 22, no. 2, pp. 322–348, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. Q. P. Wang, D. H. Lai, X. Q. Zhu, X. G. Chen, and Z. R. Lun, “Human angiostrongyliasis,” The Lancet Infectious Diseases, vol. 8, no. 10, pp. 621–630, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. R. L. Caldeira, C. L. G. F. Mendonça, C. O. Goveia et al., “First record of molluscs naturally infected with Angiostrongylus cantonensis (Chen, 1935) (Nematoda: Metastrongylidae) in Brazil,” Memorias do Instituto Oswaldo Cruz, vol. 102, no. 7, pp. 887–889, 2007. View at Google Scholar · View at Scopus
  8. J. H. Diaz, “Helminthic eosinophilic meningitis: emerging zoonotic diseases in the South,” The Journal of the Louisiana State Medical Society, vol. 160, no. 6, pp. 333–342, 2008. View at Google Scholar · View at Scopus
  9. T. Pincay, L. García, E. Narváez, O. Decker, L. Martini, and J. M. Moreira, “Angiostrongyliasis due to Parastrongylus (Angiostrongylus) cantonensis in Ecuador. First report in South America,” Tropical Medicine & International Health, vol. 14, no. 2, p. 37, 2009. View at Google Scholar
  10. A. Maldonado Jr., R. O. Simões, A. P. M. Oliveira et al., “First report of Angiostrongylus cantonensis (Nematoda: Metastrongylidae) in Achatina fulica (Mollusca: Gastropoda) from Southeast and South Brazil,” Memorias do Instituto Oswaldo Cruz, vol. 105, no. 7, pp. 938–941, 2010. View at Google Scholar · View at Scopus
  11. C. A. Behm and K. S. Ovington, “The role of eosinophils in parasitic helminth infections: insights from genetically modified mice,” Parasitology Today, vol. 16, no. 5, pp. 202–209, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. M. E. Rothenberg and S. P. Hogan, “The eosinophil,” Annual Review of Immunology, vol. 24, pp. 147–174, 2006. View at Google Scholar
  13. S. J. Ackerman and B. S. Bochner, “Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders,” Immunology and Allergy Clinics of North America, vol. 27, no. 3, pp. 357–375, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. K. Yoshimura, K. Uchida, K. Sato, and H. Oya, “Ultrastructural evidence for eosinophil-mediated destruction of Angiostrongylus cantonensis transferred into the pulmonary artery of non-permissive hosts,” Parasite Immunology, vol. 6, no. 2, pp. 105–118, 1984. View at Google Scholar · View at Scopus
  15. O. Sasaki, H. Sugaya, K. Ishida, and K. Yoshimura, “Ablation of eosinophils with anti-IL-5 antibody enhances the survival of intracranial worms of Angiostrongylus cantonensis in the mouse,” Parasite Immunology, vol. 15, no. 6, pp. 349–354, 1993. View at Google Scholar · View at Scopus
  16. H. Sugaya, M. Aoki, T. Yoshida, K. Takatsu, and K. Yoshimura, “Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 receptor α chain-knockout mice infected with Angiostrongylus cantonensis,” Parasitology Research, vol. 83, no. 6, pp. 583–590, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Sugaya, C. Graeff-Teixeira, K. Ishida, S. Matsuda, K. Katahira, and K. Yoshimura, “Interleukin-5 transgenic mice show augmented resistance to Angiostrongylus costaricensis infection,” Parasitology Research, vol. 88, no. 4, pp. 350–355, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. P. M. Intapan, S. Kittimongkolma, K. Niwattayakul, K. Sawanyawisuth, and W. Maleewong, “Cerebrospinal fluid cytokine responses in human eosinophilic meningitis associated with angiostrongyliasis,” Journal of the Neurological Sciences, vol. 267, no. 1-2, pp. 17–21, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. Z. Diao, X. Chen, C. Yin, J. Wang, H. Qi, and A. Ji, “Angiostrongylus cantonensis: effect of combination therapy with albendazole and dexamethasone on Th cytokine gene expression in PBMC from patients with eosinophilic meningitis,” Experimental Parasitology, vol. 123, no. 1, pp. 1–5, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. K. M. Chen and S. C. Lai, “Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 2, pp. 264–276, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. W. Y. Du, J. W. Liao, C. K. Fan, and K. E. Su, “Combined treatment with interleukin-12 and mebendazole lessens the severity of experimental eosinophilic meningitis caused by Angiostrongylus cantonensis in ICR mice,” Infection and Immunity, vol. 71, no. 7, pp. 3947–3953, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. C. C. Chuang, K. E. Su, C. W. Chen et al., “Anti-CCR3 monoclonal antibody inhibits eosinophil infiltration in Angiostrongylus cantonensis-infected ICR mice,” Acta Tropica, vol. 113, no. 3, pp. 209–213, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. K. Ishida and K. Yoshimura, “Differences in responses of rat- and guinea-pig-eosinophils to eosinophil chemotactic factors derived from Angiostrongylus cantonensis,” Parasite Immunology, vol. 12, no. 3, pp. 269–283, 1990. View at Google Scholar · View at Scopus
  24. S. Reinhardt, I. Scott, and H. V. Simpson, “Neutrophil and eosinophil chemotactic factors in the excretory/secretory products of sheep abomasal nematode parasites: NCF and ECF in abomasal nematodes,” Parasitology Research, vol. 109, no. 3, pp. 627–635, 2011. View at Publisher · View at Google Scholar · View at PubMed
  25. J. D. Lee and C. M. Yen, “Protease secreted by the infective larvae of Angiostrongylus cantonensis and its role in the penetration of mouse intestine,” American Journal of Tropical Medicine and Hygiene, vol. 72, no. 6, pp. 831–836, 2005. View at Google Scholar · View at Scopus
  26. A. L. Morassutti, P. M. Pinto, B. K. Dutra, G. T. Oliveira, H. B. Ferreira, and C. Graeff-Teixeira, “Detection of anti-oxidant enzymatic activities and purification of glutathione transferases from Angiostrongylus cantonensis,” Experimental Parasitology, vol. 127, no. 2, pp. 365–369, 2011. View at Publisher · View at Google Scholar · View at PubMed
  27. A. L. Morassutti, K. Levert, P. M. Pinto, A. J. da Silva, P. Wilkins, and C. Graeff-Teixeira, “Characterization of Angiostrongylus cantonensis excretory-secretory proteins as potential diagnostic targets,” Experimental Parasitology, vol. 130, no. 1, pp. 26–31, 2012. View at Publisher · View at Google Scholar · View at PubMed
  28. S. Donnelly, S. M. O'Neill, M. Sekiya, G. Mulcahy, and J. P. Dalton, “Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages,” Infection and Immunity, vol. 73, no. 1, pp. 166–173, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. S. Donnelly, C. M. Stack, S. M. O'Neill, A. A. Sayed, D. L. Williams, and J. P. Dalton, “Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages,” FASEB Journal, vol. 22, no. 11, pp. 4022–4032, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. A. A. Sayed, S. K. Cook, and D. L. Williams, “Redox balance mechanisms in Schistosoma mansoni rely on peroxiredoxins and albumin and implicate peroxiredoxins as novel drug targets,” Journal of Biological Chemistry, vol. 281, no. 25, pp. 17001–17010, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. F. U. Hartl and M. Hayer-Hartl, “Molecular chaperones in the cytosol: from nascent chain to folded protein,” Science, vol. 295, no. 5561, pp. 1852–1858, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. A. Zocevic, P. Mace, I. Vallee et al., “Identification of Trichinella spiralis early antigens at the pre-adult and adult stages,” Parasitology, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. B. Vergnes, B. Gourbal, I. Girard, S. Sundar, J. Drummelsmith, and M. Ouellette, “A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death,” Molecular and Cellular Proteomics, vol. 6, no. 1, pp. 88–101, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. F. Piano, A. J. Schetter, M. Mangone, L. Stein, and K. J. Kemphues, “RNAi analysis of genes expressed in the ovary of Caenorhabditis elegans,” Current Biology, vol. 10, no. 24, pp. 1619–1622, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Inoue, K. Hirata, Y. Kuwana et al., “Cell cycle control by daf-21/Hsp90 at the first meiotic prophase/metaphase boundary during oogenesis in Caenorhabditis elegans,” Development Growth and Differentiation, vol. 48, no. 1, pp. 25–32, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. Lígia Bender, R. Lucyk Maurer, M. C. Fernandes da Silva et al., “Eggs and reproductive organs of female Angiostrongylus costaricensis are more intensely recognized by human sera from acute phase in abdominal anglostrongyliasis,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 36, no. 4, pp. 449–454, 2003. View at Google Scholar · View at Scopus
  37. A. Oladiran and M. Belosevic, “Trypanosoma carassii hsp70 increases expression of inflammatory cytokines and chemokines in macrophages of the goldfish (Carassius auratus L.),” Developmental and Comparative Immunology, vol. 33, no. 10, pp. 1128–1136, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. F. Hauet-Broere, L. Wieten, T. Guichelaar, S. Berlo, R. Van Der Zee, and W. Van Eden, “Heat shock proteins induce T cell regulation of chronic inflammation,” Annals of the Rheumatic Diseases, vol. 65, no. 3, pp. iii65–iii68, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. D. R. Schultz and P. I. Arnold, “Heat shock (stress) proteins and autoimmunity in rheumatic diseases,” Seminars in Arthritis and Rheumatism, vol. 22, no. 6, pp. 357–374, 1993. View at Google Scholar · View at Scopus
  40. M. A. Toscano, A. G. Commodaro, J. M. Ilarregui et al., “Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses,” Journal of Immunology, vol. 176, no. 10, pp. 6323–6332, 2006. View at Google Scholar · View at Scopus
  41. S. Katoh, N. Ishii, A. Nobumoto et al., “Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 1, pp. 27–35, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. J. P. Hewitson, Y. M. Harcus, R. S. Curwen et al., “The secretome of the filarial parasite, Brugia malayi: proteomic profile of adult excretory-secretory products,” Molecular and Biochemical Parasitology, vol. 160, no. 1, pp. 8–21, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. A. D. Klion and J. E. Donelson, “OvGa1BP, a filarial antigen with homology to vertebrate galactoside- binding proteins,” Molecular and Biochemical Parasitology, vol. 65, no. 2, pp. 305–315, 1994. View at Publisher · View at Google Scholar · View at Scopus
  44. C. H. Hokke and M. Yazdanbakhsh, “Schistosome glycans and innate immunity,” Parasite Immunology, vol. 27, no. 7-8, pp. 257–264, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. I. van Die and R. D. Cummings, “Glycan gimmickry by parasitic helminths: a strategy for modulating the host immune response?” Glycobiology, vol. 20, no. 1, pp. 2–12, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. E. van Liempt, S. J. van Vliet, A. Engering et al., “Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation,” Molecular Immunology, vol. 44, no. 10, pp. 2605–2615, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. M. Kiel, P. Josh, A. Jones, R. Windon, P. Hunt, and K. Kongsuwan, “Identification of immuno-reactive proteins from a sheep gastrointestinal nematode, Trichostrongylus colubriformis, using two-dimensional electrophoresis and mass spectrometry,” International Journal for Parasitology, vol. 37, no. 13, pp. 1419–1429, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. M. S. Pearson, J. M. Bethony, D. A. Pickering et al., “An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection,” FASEB Journal, vol. 23, no. 9, pp. 3007–3019, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. P. S. Sijwali, J. Koo, N. Singh, and P. J. Rosenthal, “Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum,” Molecular and Biochemical Parasitology, vol. 150, no. 1, pp. 96–106, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. M. E. Morales, G. Rinaldi, G. N. Gobert, K. J. Kines, J. F. Tort, and P. J. Brindley, “RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade,” Molecular and Biochemical Parasitology, vol. 157, no. 2, pp. 160–168, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. M. Sajid and J. H. McKerrow, “Cysteine proteases of parasitic organisms,” Molecular and Biochemical Parasitology, vol. 120, no. 1, pp. 1–21, 2002. View at Google Scholar · View at Scopus
  52. M. H. Shin, Y. B. Chung, and H. Kita, “Degranulation of human eosinophils induced by Paragonimus westermani-secreted protease,” The Korean Journal of Parasitology, vol. 43, no. 1, pp. 33–37, 2005. View at Google Scholar · View at Scopus
  53. Y. H. Liu, Y. P. Han, Z. Y. Li et al., “Molecular cloning and characterization of cystatin, a cysteine protease inhibitor, from Angiostrongylus cantonensis,” Parasitology Research, vol. 107, no. 4, pp. 915–922, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. S. Hartmann and R. Lucius, “Modulation of host immune responses by nematode cystatins,” International Journal for Parasitology, vol. 33, no. 11, pp. 1291–1302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Zavasnik-Bergant, “Cystatin protease inhibitors and immune functions,” Frontiers in Bioscience, vol. 13, no. 12, pp. 4625–4637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Schnoeller, S. Rausch, S. Pillai et al., “A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages,” Journal of Immunology, vol. 180, no. 6, pp. 4265–4272, 2008. View at Google Scholar · View at Scopus
  57. A. Delaney, A. Williamson, A. Brand et al., “Cloning and characterisation of an aspartyl protease inhibitor (API-1) from Ancylostoma hookworms,” International Journal for Parasitology, vol. 35, no. 3, pp. 303–313, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. W. Fang, S. Xu, Y. Wang et al., “ES proteins analysis of Angiostrongylus cantonensis: products of the potential parasitism genes?” Parasitology Research, vol. 106, no. 5, pp. 1027–1032, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus